Current version: 1.1, last update: 1 year ago
First release : 22 Sep 2021
App size: 114.6 Mb
A clinical study app focused on on evaluating the safety and efficacy of Amcenestrant plus palbociclib as first line therapy for patients with ER(+) HER2(-) advanced breast cancer.